AMPH vs VRTX · P/E 12, rev $732.0M vs P/E 30, rev $12.00B
Amphastar P (AMPH) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Amphastar P (AMPH) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported AMPH revenue for 2024-12-31 was $732.0M. Net income was $159.5M. Revenue was up 13.6% from 2023-12-31 to 2024-12-31. AMPH currently screens at market cap $880.1M and trailing P/E 12.0.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
AMPH currently screens at market cap $880.1M and trailing P/E 12.0. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the AMPH and VRTX stock pages for the full models.
Not investment advice.